Free tool
Stocks listed on XETRA
We cover 45 companies listed on XETRA. The median market value in the group is $32.39B. Across the group, the median move over the past trading day is +0.78%. 62% of the 39 with a 200-day average trade above it. Price change over the past year runs from −27.5% to +66.5% across the middle 80 percent of the group, with a median of +7.2%.
Other lists in this group
Table
45 of 1,273 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| GIS.DE | Gilead Sciences, Inc. | $184.35B | Large cap | +33.64% | Oct 29, 2026 |
| PFE.DE | Pfizer Inc. | $161.11B | Large cap | +22.96% | Nov 3, 2026 |
| DAP.DE | Danaher Corporation | $151.59B | Large cap | +6.90% | Oct 20, 2026 |
| VX1.DE | Vertex Pharmaceuticals Incorporated | $139.82B | Large cap | +41.64% | Nov 2, 2026 |
| BRM.DE | Bristol-Myers Squibb Company | $137.92B | Large cap | +50.84% | Oct 29, 2026 |
| IUI1.DE | Intuitive Surgical, Inc. | $131.98B | Large cap | −21.06% | Oct 20, 2026 |
| SYK.DE | Stryker Corporation | $126.78B | Large cap | +34.90% | Oct 29, 2026 |
| 2M6.DE | Medtronic plc | $117.57B | Large cap | +2.65% | Sep 1, 2026 |
| SNW.DE | Sanofi | $109.40B | Large cap | −2.82% | Oct 30, 2026 |
| GS71.DE | GSK plc | $103.63B | Large cap | +34.79% | Oct 28, 2026 |
| A58.DE | Elevance Health, Inc. | $87.59B | Large cap | −19.30% | Oct 21, 2026 |
| RGO.DE | Regeneron Pharmaceuticals, Inc. | $84.24B | Large cap | −5.91% | Oct 28, 2026 |
| CGN.DE | The Cigna Group | $74.86B | Large cap | −8.78% | Nov 5, 2026 |
| BSX.DE | Boston Scientific Corporation | $69.12B | Large cap | −53.11% | Oct 28, 2026 |
| 0QF.DE | Moderna, Inc. | $59.07B | Large cap | +550.51% | Nov 5, 2026 |
| BAYN.DE | Bayer Aktiengesellschaft | $56.25B | Large cap | +76.91% | Nov 3, 2026 |
| EWL.DE | Edwards Lifesciences Corporation | $52.39B | Large cap | +11.65% | Oct 29, 2026 |
| BOX.DE | Becton, Dickinson and Company | $51.84B | Large cap | +1.73% | Nov 5, 2026 |
| IX1.DE | IDEXX Laboratories, Inc. | $44.14B | Large cap | +17.97% | Nov 2, 2026 |
| 2U3.DE | Alcon Inc. | $35.20B | Large cap | −7.70% | Nov 10, 2026 |
| ILU.DE | Illumina, Inc. | $34.08B | Large cap | +129.80% | Oct 29, 2026 |
| DC4.DE | DexCom, Inc. | $33.35B | Large cap | +21.06% | Oct 29, 2026 |
| IDP.DE | Biogen Inc. | $32.39B | Large cap | +65.32% | Oct 29, 2026 |
| DUL.DE | Alnylam Pharmaceuticals, Inc. | $32.28B | Large cap | −10.21% | Oct 29, 2026 |
| ZOE.DE | Zoetis Inc. | $32.08B | Large cap | −49.47% | Nov 3, 2026 |
| FRE.DE | Fresenius SE & Co. KGaA | $30.43B | Large cap | +1.64% | Nov 4, 2026 |
| 22UA.DE | BioNTech SE | $28.28B | Large cap | +14.09% | Nov 3, 2026 |
| 56S1.DE | Sartorius Stedim Biotech S.A. | $21.77B | Large cap | +11.32% | Oct 22, 2026 |
| GE9.DE | Genmab A/S | $20.65B | Large cap | −11.12% | Nov 5, 2026 |
| VIA.DE | Viatris Inc. | $19.41B | Large cap | +67.32% | Nov 5, 2026 |
| QS51.DE | Straumann Holding AG | $18.40B | Large cap | −1.10% | Oct 28, 2026 |
| CBHD.DE | Coloplast A/S | $15.94B | Large cap | +7.91% | Nov 3, 2026 |
| SRT.DE | Sartorius Aktiengesellschaft | $15.54B | Large cap | +21.79% | Oct 22, 2026 |
| FME.DE | Fresenius Medical Care AG | $12.64B | Large cap | −2.61% | Nov 3, 2026 |
| AFW.DE | Align Technology, Inc. | $11.26B | Large cap | −54.37% | Oct 28, 2026 |
| QIA.DE | Qiagen N.V. | $8.99B | Mid cap | −6.73% | Nov 4, 2026 |
| OBCK.DE | Ottobock SE & Co. KGaA | $4.40B | Mid cap | +0.68% | Nov 12, 2026 |
| BBZA.DE | BB Biotech AG | $3.87B | Mid cap | +7.22% | Oct 23, 2026 |
| FIE.DE | Fielmann Group AG | $3.79B | Mid cap | −27.31% | Aug 27, 2026 |
| 22Z.DE | Zealand Pharma A/S | $3.37B | Mid cap | −28.16% | Nov 12, 2026 |
| B72.DE | AtaiBeckley Inc. | $2.79B | Mid cap | +59.69% | Nov 12, 2026 |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% | Nov 13, 2026 |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% | Oct 29, 2026 |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% | Nov 12, 2026 |
| PSH0.DE | Sernova Biotherapeutics Inc | $30.82M | Micro cap | −27.68% | Sep 10, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.